A citation-based method for searching scientific literature

Matthew D Hellmann, Tudor-Eliade Ciuleanu, Adam Pluzanski, Jong Seok Lee, Gregory A Otterson, Clarisse Audigier-Valette, Elisa Minenza, Helena Linardou, Sjaak Burgers, Pamela Salman, Hossein Borghaei, Suresh S Ramalingam, Julie Brahmer, Martin Reck, Kenneth J O'Byrne, William J Geese, George Green, Han Chang, Joseph Szustakowski, Prabhu Bhagavatheeswaran, Diane Healey, Yali Fu, Faith Nathan, Luis Paz-Ares. N Engl J Med 2018
Times Cited: 1394



Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell, Susanna Y-S Cheng, Helge G Bischoff, Nir Peled, Francesco Grossi, Ross R Jennens, Martin Reck, Rina Hui, Edward B Garon, Michael Boyer, Belén Rubio-Viqueira, Silvia Novello, Takayasu Kurata, Jhanelle E Gray, John Vida, Ziwen Wei, Jing Yang, Harry Raftopoulos, M Catherine Pietanza, Marina C Garassino. N Engl J Med 2018
Times Cited: 2150




List of shared articles



Times cited

Advances in Small-Cell Lung Cancer (SCLC) Translational Research.
Benjamin J Drapkin, Charles M Rudin. Cold Spring Harb Perspect Med 2021
3

Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms.
Mu-Yang Huang, Xiao-Ming Jiang, Bing-Lin Wang, Yang Sun, Jin-Jian Lu. Pharmacol Ther 2021
3


The cutting-edge progress of immune-checkpoint blockade in lung cancer.
Fei Zhou, Meng Qiao, Caicun Zhou. Cell Mol Immunol 2021
3


Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer.
Li Zhou, Qiuli Xu, Litang Huang, Jiajia Jin, Xueying Zuo, Qun Zhang, Liang Ye, Suhua Zhu, Ping Zhan, Jianan Ren,[...]. Cancer Lett 2021
4

A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study.
Han Si, Michael Kuziora, Katie J Quinn, Elena Helman, Jiabu Ye, Feng Liu, Urban Scheuring, Solange Peters, Naiyer A Rizvi, Philip Z Brohawn,[...]. Clin Cancer Res 2021
3

Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer - predictors of response and impact of previous radiotherapy.
Åsa Kristina Öjlert, Daniel Nebdal, Marius Lund-Iversen, Renée Åstrøm Ellefsen, Odd Terje Brustugun, Jon Michael Gran, Ann Rita Halvorsen, Åslaug Helland. Acta Oncol 2021
0

Addressing resistance to immune checkpoint inhibitor therapy: an urgent unmet need.
Siwen Hu-Lieskovan, Gabriel G Malouf, Ira Jacobs, Jeffrey Chou, Li Liu, Melissa L Johnson. Future Oncol 2021
1


[Developments in Immunotherapy for Advanced Non-small Cell Lung Cancer].
Haoyang Li, Jinghui Wang. Zhongguo Fei Ai Za Zhi 2021
0

Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case-control matched analysis from a large multicenter study.
Alessio Cortellini, Andrea De Giglio, Katia Cannita, Diego L Cortinovis, Robin Cornelissen, Cinzia Baldessari, Raffaele Giusti, Ettore D'Argento, Francesco Grossi, Matteo Santoni,[...]. Thorac Cancer 2021
6

Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data.
Elizabeth Dudnik, Mor Moskovitz, Yakir Rottenberg, Anastasiya Lobachov, Rinat Mandelboim, Tzippy Shochat, Damien Urban, Mira Wollner, Hovav Nechushtan, Ofer Rotem,[...]. Oncoimmunology 2021
1


The Comprehensive Analyses of Genomic Variations and Assessment of TMB and PD-L1 Expression in Chinese Lung Adenosquamous Carcinoma.
Yong Cheng, Yanxiang Zhang, Yuwei Yuan, Jiao Wang, Ke Liu, Bin Yu, Li Xie, Chao Ou-Yang, Lin Wu, Xiaoqun Ye. Front Genet 2021
0


Myeloid cell heterogeneity in lung cancer: implication for immunotherapy.
Sabina Sangaletti, Roberto Ferrara, Claudio Tripodo, Marina Chiara Garassino, Mario Paolo Colombo. Cancer Immunol Immunother 2021
0

Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review.
Clizia Zichi, Chiara Paratore, Piera Gargiulo, Annapaola Mariniello, Maria Lucia Reale, Marco Audisio, Maristella Bungaro, Andrea Caglio, Teresa Gamba, Francesco Perrone,[...]. Eur J Cancer 2021
0

Tumour neoantigen mimicry by microbial species in cancer immunotherapy.
Maximilian Boesch, Florent Baty, Sacha I Rothschild, Michael Tamm, Markus Joerger, Martin Früh, Martin H Brutsche. Br J Cancer 2021
0



Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis.
Shixue Chen, Zhibo Zhang, Xuan Zheng, Haitao Tao, Sujie Zhang, Junxun Ma, Zhefeng Liu, Jinliang Wang, Yuanyu Qian, Pengfei Cui,[...]. Front Oncol 2021
0

Clinical Insights Into Novel Immune Checkpoint Inhibitors.
Jii Bum Lee, Sang-Jun Ha, Hye Ryun Kim. Front Pharmacol 2021
2

Real-world study of PD-L1 testing patterns and treatment distribution in patients with metastatic non-small-cell lung cancer in Israel.
Sarah Sharman Moser, Lior Apter, Ashwini Arunachalam, Thomas Burke, Varda Shalev, Gabriel Chodick, Nava Siegelmann-Danieli. Immunotherapy 2021
0

Treatment-Related Serious Adverse Events of Immune Checkpoint Inhibitors in Clinical Trials: A Systematic Review.
Tao Ouyang, Yanyan Cao, Xuefeng Kan, Lei Chen, Yanqiao Ren, Tao Sun, Liangliang Yan, Bin Xiong, Bin Liang, Chuansheng Zheng. Front Oncol 2021
0


Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies.
Kenneth K W To, Winnie Fong, William C S Cho. Front Oncol 2021
0

0


Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC.
Michael J Grant, Roy S Herbst, Sarah B Goldberg. Nat Rev Clin Oncol 2021
1

Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung.
Yoon Jung Jang, Dong-Gon Hyun, Chang-Min Choi, Dae Ho Lee, Sang-We Kim, Shinkyo Yoon, Woo Sung Kim, Wonjun Ji, Jae Cheol Lee. BMC Cancer 2021
0

Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public Health.
Elaine Chang, Lorraine Pelosof, Steven Lemery, Yutao Gong, Kirsten B Goldberg, Ann T Farrell, Patricia Keegan, Janaki Veeraraghavan, Guo Wei, Gideon M Blumenthal,[...]. Oncologist 2021
0

Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC).
Li-Chung Chiu, Shu-Min Lin, Yu-Lun Lo, Scott Chih-Hsi Kuo, Cheng-Ta Yang, Ping-Chih Hsu. Vaccines (Basel) 2021
0